Stay updated on NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.

Latest updates to the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe history now reflects that enrollment is closed and records the new page revision v3.6.0, while the older revision tag v3.5.5 is removed.SummaryDifference0.2%

- Check16 days agoChange DetectedThe revision banner in the page footer updates from v3.5.4 to v3.5.5, indicating a minor metadata/version update to the record history.SummaryDifference0.1%

- Check23 days agoChange DetectedThere are no textual changes identified in the study record history data. The version history and current status presented remain the same.SummaryDifference0.1%

- Check30 days agoChange DetectedNo text changes were supplied for this study record history; the page remains displaying the existing version history and status disclosures.SummaryDifference0.1%

- Check37 days agoChange DetectedThe history now shows a new Revision: v3.5.4 replacing v3.5.3. This indicates an update to the ClinicalTrials.gov interface rather than changes to the study record itself.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s displayed software/UI revision number has been updated from v3.5.2 to v3.5.3, indicating a platform change rather than an update to the clinical trial record itself.SummaryDifference0.1%

Stay in the know with updates to NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.